Lotus Pharmaceutical Co., Ltd. (1795.TW) TAI

278.50

-5(-1.76%)

Updated at December 24 02:38PM

Currency In TWD

Valuation

Market Cap70.57B
Enterprise Value78.2B
P/E Ratio15.27
PEG Ratio-6.29
Price/Sales Ratio3.89
Price/Book Ratio3.26
Enterprise/Revenue4.26
Enterprise/EBITDA10.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.25
Operating Margin0.29

Management Effectiveness

Return On Assets0.12
Return On Equity0.22

Income Statement

Revenue18.58B
Revenue/Share71.91
Gross Profit10.92B
EBITDA8.21B
Net Income5.07B
Diluted EPS19.26

Balance Sheet

Total Cash5.67B
Total Cash/Share21.85
Total Debt12.42B
Total Debt/Equity0.56
Current Ratio1.81
Book Value Per Share85.46

Price History

52-Week Change4.7
52-Week High328
52-Week Low172.5
Moving Average 50 Days289.9
Moving Average 200 Days238.4

Statistics

Average Volume4.84M
Shares Outstanding260.91M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5.78
Trailing Annual Dividend Yield2.07
Payout Ratio0.32
Last Split Factor53:50
Last Split DateSeptember 08, 2010